Administration of mylotarg 4 days after beginning of a chemotherapy including intermediate-dose aracytin and mitoxantrone (MIDAM regimen) produces a high rate of complete hematologic remission in patients with CD33+ primary resistant or relapsed acu
| Image |  |
|---|---|
| Description | scientific article published on 8 April 2005 |
| Author/s |
author: Herve Avet-Loiseau Noel Jean Milpied Philippe Moreau |
| Publication date | April 8, 2005 |
| Language | |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |